1 - Procurement of contrast media 1.

Auto-translated from hu

Original title: 1 - Kontrasztanyagok beszerzése 1.

Budapesti Uzsoki Utcai Kórház

Published: Apr 23, 2026

Updated: May 22, 2026

Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to PHOENIX Pharma Gyógyszerkereskedelmi Zártkörűen Működő Részvénytársaság; Clear Pharma Zrt. — €14,646,708

Browse open Health & Medical tenders in Hungary

About This Opportunity

Translated

Direct orders for contrast media with ATC code V08AB02 will be placed under the framework agreement, with a base quantity commitment.

This is a supplies contract in the health and medical services sector. Located in Hungary, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: hu

A keretmegállapodás alapján az alábbi kontrasztanyagok kerülnek közvetlen megrendelésre a keretmegállapodás második részében. (KM II. része) V08AB02 ATC kódú (jelű) kontrasztanyag; 2 éves alapmennyiség (nettó 42 836 177,- Ft), mely alapmennyiség vonatkozásában AK lehívási kötelezettséget vállal: 1. - Hatóanyag: iohexol 100 ml; Hatáserősség: 350; Egys.: mg I/ml; 2 éves tervezett mennyiség: 40 000 ml 2. - Hatóanyag: iohexol 500 ml; Hatáserősség: 350; Egys.: mg I/ml; 2 éves tervezett mennyiség: 600 000 ml A részletes feltételeket a közbeszerzési dokumentumok tartalmazzák. AK igényeinek kizárólag a KD-ban meghatározott műszaki követelményeknek megfelelő áru felel meg. További részletek a KD részét képező Műszaki Leírásban és a szerződés-tervezetben.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on April 23, 2026. Last refreshed 35 days ago. Original language: hu. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Budapesti Uzsoki Utcai Kórház

Budapesti Uzsoki Utcai Kórház has issued 31 procurement notices on BidsFactory, including 0 currently open and 10 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for Hungary. Notices are distributed via Hungary EKR and TED - Tenders Electronic Daily (EU). Most recent publication: May 28, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to PHOENIX Pharma Gyógyszerkereskedelmi Zártkörűen Működő Részvénytársaság; Clear Pharma Zrt.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Budapesti Uzsoki Utcai Kórház in Hungary. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

PHOENIX Pharma Gyógyszerkereskedelmi Zártkörűen Működő Részvénytársaság; Clear Pharma Zrt. was awarded the contract for €14,646,708. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Hungary. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.